Similar articles

• Exendin-4 reverts behavioural and neurochemical dysfunction in a pre-motor rodent model of Parkinson's disease with noradrenergic deficit.

  Rampersaud N, Harkavyi A, Giordano G, Lever R, Whitton J, Whitton P. Rampersaud N, et al. Br J Pharmacol. 2012 Dec;167(7):1467-79. doi: 10.1111/j.1476-5381.2012.02100.x. Br J Pharmacol. 2012. Retraction in: Br J Pharmacol. 2013 Jun;169(3):717. doi: 10.1111/bph.12241. PMID: 22774922 Free PMC article. Retracted.
• Retraction. Exendin-4 reverses biochemical and behavioural deficits in a pre-motor rodent model of Parkinson's disease with combined noradrenergic and serotonergic lesions.

  [No authors listed] [No authors listed] Neuropeptides. 2013 Jun;47(3):221. Neuropeptides. 2013. PMID: 23866374 No abstract available.
• Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson's disease with combined noradrenergic and serotonergic lesions.

  Rampersaud N, Harkavyi A, Giordano G, Lever R, Whitton J, Whitton PS. Rampersaud N, et al. Neuropeptides. 2012 Oct;46(5):183-93. doi: 10.1016/j.npep.2012.07.004. Epub 2012 Aug 22. Neuropeptides. 2012. Retraction in: Neuropeptides. 2013 Jun;47(3):221. PMID: 22921965 Retracted.
• The Noradrenergic System in Parkinson's Disease.

  Paredes-Rodriguez E, Vegas-Suarez S, Morera-Herreras T, De Deurwaerdere P, Miguelez C. Paredes-Rodriguez E, et al. Front Pharmacol. 2020 Apr 8;11:435. doi: 10.3389/fphar.2020.00435. eCollection 2020. Front Pharmacol. 2020. PMID: 32322208 Free PMC article. Review.
• Neurogenic bowel dysfunction in patients with spinal cord injury, myelomeningocele, multiple sclerosis and Parkinson's disease.

  Awad RA. Awad RA. World J Gastroenterol. 2011 Dec 14;17(46):5035-48. doi: 10.3748/wjg.v17.i46.5035. World J Gastroenterol. 2011. PMID: 22171138 Free PMC article. Review.